Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.

Loffler CA, Macdougall C.

Expert Rev Anti Infect Ther. 2007 Dec;5(6):961-81.

PMID:
18039081
2.

Antimicrobial agents in treatment of MRSA infections.

Johnson MD, Decker CF.

Dis Mon. 2008 Dec;54(12):793-800. doi: 10.1016/j.disamonth.2008.09.002. Review. No abstract available.

PMID:
18996282
3.

Treatment of infections caused by resistant Staphylococcus aureus.

Anstead GM, Quinones-Nazario G, Lewis JS 2nd.

Methods Mol Biol. 2007;391:227-58. Review.

PMID:
18025681
4.

New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.

Schmidt-Ioanas M, de Roux A, Lode H.

Curr Opin Crit Care. 2005 Oct;11(5):481-6. Review.

PMID:
16175036
6.

[Staphylococcus aureus and antibiotic resistance].

Sancak B.

Mikrobiyol Bul. 2011 Jul;45(3):565-76. Review. Turkish.

PMID:
21935792
7.

Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.

Twilla JD, Gelfand MS, Cleveland KO, Usery JB.

J Antimicrob Chemother. 2011 Nov;66(11):2675-7. doi: 10.1093/jac/dkr329. Epub 2011 Aug 10. No abstract available.

PMID:
21831987
8.

In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China.

Wang H, Liu Y, Sun H, Xu Y, Xie X, Chen M.

Diagn Microbiol Infect Dis. 2008 Oct;62(2):226-9. doi: 10.1016/j.diagmicrobio.2008.06.003. Epub 2008 Jul 23.

PMID:
18653301
9.
10.

New treatments for methicillin-resistant Staphylococcus aureus.

Stryjewski ME, Corey GR.

Curr Opin Crit Care. 2009 Oct;15(5):403-12. doi: 10.1097/MCC.0b013e32832f0a74. Review.

PMID:
19561492
11.

Treatment of methicillin-resistant Staphylococcus aureus surgical site infections.

Santayana EM, Jourjy J.

AACN Adv Crit Care. 2011 Jan-Mar;22(1):5-12; quiz 14. doi: 10.1097/NCI.0b013e3181ef86fe2049019. Review. No abstract available.

PMID:
21297385
12.

Methicillin-resistant Staphylococcus aureus: the superbug.

Ippolito G, Leone S, Lauria FN, Nicastri E, Wenzel RP.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S7-11. doi: 10.1016/j.ijid.2010.05.003. Epub 2010 Sep 20. Review.

13.

Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.

Micek ST.

Clin Infect Dis. 2007 Sep 15;45 Suppl 3:S184-90. Review.

PMID:
17712745
14.

Registered and investigational drugs for the treatment of methicillin-resistant Staphylococcus aureus infection.

Pan A, Lorenzotti S, Zoncada A.

Recent Pat Antiinfect Drug Discov. 2008 Jan;3(1):10-33. Review.

PMID:
18221183
15.

Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.

Leonard SN, Cheung CM, Rybak MJ.

Antimicrob Agents Chemother. 2008 Aug;52(8):2974-6. doi: 10.1128/AAC.00257-08. Epub 2008 Jun 2.

16.

Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections.

Ellis MW, Lewis JS 2nd.

Curr Opin Infect Dis. 2005 Dec;18(6):496-501. Review.

PMID:
16258322
17.

Treatment of infections due to resistant Staphylococcus aureus.

Anstead GM, Cadena J, Javeri H.

Methods Mol Biol. 2014;1085:259-309. doi: 10.1007/978-1-62703-664-1_16. Review.

PMID:
24085702
18.

[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].

Mensa J, Soriano A, Llinares P, Barberán J, Montejo M, Salavert M, Alvarez-Rocha L, Maseda E, Moreno A, Pasquau J, Gómez J, Parra J, Candel J, Azanza JR, García JE, Marco F, Soy D, Grau S, Arias J, Fortún J, de Alarcón CA, Picazo J; Sociedad Española de Quimioterapia (SEQ).; Sociedad Española de Medicina Interna (SEMI).; GTIPO-Sociedad Española de Anestesiología y Reanimación..

Rev Esp Quimioter. 2013 Jan;26 Suppl 1:1-84. Review. Spanish. No abstract available.

19.

[Vancomycin, what else?].

Daurel C, Leclercq R.

Arch Pediatr. 2010 Sep;17 Suppl 4:S121-8. doi: 10.1016/S0929-693X(10)70912-X. French.

PMID:
20826319
20.

Efficacy of dalbavancin against methicillin-resistant Staphylococcus aureus in the rat granuloma pouch infection model.

Jabés D, Candiani G, Romanó G, Brunati C, Riva S, Cavaleri M.

Antimicrob Agents Chemother. 2004 Apr;48(4):1118-23.

Supplemental Content

Support Center